TipRanks on MSN
Inovio 13.16M share Spot Secondary priced at $1.90
Pharmaceuticals announced the pricing of an underwritten public offering of 13,158,000 shares of its common stock at a public ...
US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...
Investing.com -- INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% after the biotechnology company announced the pricing of an underwritten public offering at $1.90 per share, representing a ...
Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review ...
InvestorsHub on MSN
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering
INOVIO Pharmaceuticals Inc. (NASDAQ:INO) shares fell 10% in early trading after the biotech company announced the pricing of ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (the "Company"), today announced that it has entered into a securities purchase agreement with a single healthcare ...
Inovio Pharmaceuticals Inc (INO) showcases significant progress in its BLA submission for INO-3107, while navigating ...
Ahead of the opening bell, the drugmaker said it plans to sell about 13.2 million shares of common stock at $1.90 apiece. Inovio will also grant underwriters a 30-day option to purchase up to nearly 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback